RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Radius Health Stock

Radius Health ROE 2024

Radius Health ROE

-0.03

Ticker

RDUS

ISIN

US7504692077

WKN

A114VH

In 2024, Radius Health's return on equity (ROE) was -0.03, a -116.06% increase from the 0.18 ROE in the previous year.

Radius Health Aktienanalyse

What does Radius Health do?

Radius Health Inc. is an American pharmaceutical company specializing in the research, development, and marketing of products in the areas of osteoporosis, cancer therapy, and endocrinology. The company was founded in 2003 and is headquartered in Waltham, Massachusetts. The history of Radius Health Inc. began with the discovery of a new compound called Abaloparatide, which was intended for use in the treatment of osteoporosis. The company initiated a Phase III clinical trial to evaluate the efficacy and tolerability of the medication. In 2016, Abaloparatide was approved by the U.S. Food and Drug Administration (FDA) for the treatment of postmenopausal osteoporosis. Since then, Radius Health Inc. has evolved into a leading company specializing in improving women's health. The company has expanded its activities to include oncology and endocrinology and relies on innovative technologies and research to provide better treatment options and medications for patients. The business model of Radius Health Inc. is based on the development and marketing of cost-effective and effective products for the treatment of diseases. The company conducts extensive clinical research and strives to develop new drugs and therapies to improve the lives of women. Radius Health Inc. employs an open and agile corporate culture that promotes innovation and prioritizes the needs of patients. The products offered by Radius Health Inc. include a wide range of medications used in the treatment of osteoporosis, breast cancer, and other diseases. Abaloparatide, the company's flagship product, is a recombinant peptide agonist that stimulates bone formation and reduces the risk of fractures in postmenopausal women. Other products include Elacestrant, an investigative drug for the treatment of breast cancer, and RAD1901, a selective estrogen receptor modulator used in the treatment of hormone-dependent cancers. The company is also active in the field of digital health. Radius Health Inc. has developed an augmented reality app that assists doctors and patients in visualizing bone fractures and other conditions. The app is currently being tested in clinical trials and is expected to be widely used in the future. Overall, Radius Health Inc. is known for its innovative research activities and efforts to improve women's health. The company has an experienced and dedicated team of researchers, scientists, and executives working together to create better treatment options for patients. With a strong pipeline of products and a vision for the future of healthcare, Radius Health Inc. is on track to become a leading provider of medical products and services. Radius Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Radius Health's Return on Equity (ROE)

Radius Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Radius Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Radius Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Radius Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Radius Health stock

What is the ROE (Return on Equity) of Radius Health this year?

The ROE of Radius Health this year is -0.03 undefined.

How has the Return on Equity (ROE) of Radius Health developed compared to the previous year?

The ROE of Radius Health has increased by -116.06% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Radius Health?

A high ROE indicates that Radius Health generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Radius Health?

A low ROE can indicate that Radius Health is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Radius Health affect the company?

A change in ROE (Return on Equity) of Radius Health can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Radius Health?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Radius Health?

Some factors that can influence Radius Health's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Radius Health pay?

Over the past 12 months, Radius Health paid a dividend of 0.75 USD . This corresponds to a dividend yield of about 3.94 %. For the coming 12 months, Radius Health is expected to pay a dividend of 0.86 USD.

What is the dividend yield of Radius Health?

The current dividend yield of Radius Health is 3.94 %.

When does Radius Health pay dividends?

Radius Health pays a quarterly dividend. This is distributed in the months of December, March, May, August.

How secure is the dividend of Radius Health?

Radius Health paid dividends every year for the past 1 years.

What is the dividend of Radius Health?

For the upcoming 12 months, dividends amounting to 0.86 USD are expected. This corresponds to a dividend yield of 4.52 %.

In which sector is Radius Health located?

Radius Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Radius Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Radius Health from 8/5/2024 amounting to 0.188 USD, you needed to have the stock in your portfolio before the ex-date on 7/22/2024.

When did Radius Health pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Radius Health in the year 2023?

In the year 2023, Radius Health distributed 0.75 USD as dividends.

In which currency does Radius Health pay out the dividend?

The dividends of Radius Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Radius Health

Our stock analysis for Radius Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Radius Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.